Alternating hemiplegia of childhood – Diagnostics – Overview of Information and Clinical Research

Diagnosing alternating hemiplegia of childhood can be challenging because the condition is extremely rare and often mimics other neurological disorders, particularly epilepsy. Understanding the diagnostic process—from recognizing the early warning signs to confirming the diagnosis through genetic testing—can help families and physicians identify this complex brain disorder more quickly and avoid years of misdiagnosis.

Introduction: Who Should Seek Diagnostic Testing and When

Parents and caregivers should seek medical evaluation if their infant or young child begins experiencing unusual episodes of weakness, paralysis, or muscle stiffness, especially if these episodes affect one side of the body or alternate between sides. The most critical window for recognizing alternating hemiplegia of childhood is during the first 18 months of life, when symptoms typically first appear.^[1]

Early diagnosis of this condition is particularly important because many children are initially misdiagnosed with epilepsy. The stiffening episodes seen in alternating hemiplegia of childhood can closely resemble epileptic seizures, and the weakness that follows can look similar to the fatigue that sometimes occurs after a seizure. However, the two conditions require very different treatment approaches, and medications used for epilepsy may not help—and could even cause unnecessary side effects—in children with alternating hemiplegia of childhood.^[2]

Physicians should consider diagnostic evaluation for alternating hemiplegia of childhood when an infant or toddler presents with several concerning signs. These include episodes of temporary paralysis that seem to move from one side of the body to the other, unusual eye movements that appear jerky or uncontrolled, muscle stiffness that comes and goes, or developmental delays in reaching normal milestones. A particularly telling characteristic is that these symptoms disappear completely during sleep but may return shortly after the child wakes up.^[1]

Increasing awareness among healthcare providers about alternating hemiplegia of childhood has made early diagnosis more common than in the past. Getting an accurate diagnosis as soon as possible helps families avoid the frustration and expense of trying ineffective treatments. It also allows children to access appropriate therapies and medications more quickly, which can make a meaningful difference in their quality of life and development.^[2]

⚠️ Important

Because alternating hemiplegia of childhood is so rare—affecting approximately one in one million people—and because its symptoms overlap with more common conditions like epilepsy, many children go years without a correct diagnosis. If your child’s symptoms do not improve with standard epilepsy treatments, or if episodes consistently disappear with sleep, discuss the possibility of alternating hemiplegia of childhood with your neurologist.

Classic Diagnostic Methods for Identifying the Disease

The diagnostic process for alternating hemiplegia of childhood relies heavily on a thorough medical history and careful observation of the child’s symptoms. Physicians need to gather detailed information about when symptoms first appeared, how long episodes last, what triggers them, and whether sleep provides relief. This comprehensive history is considered the cornerstone of diagnosis because there is no single test result that can definitively confirm or rule out the condition on its own.^[3]

The original diagnostic criteria, known as the Aicardi criteria, provided a framework that many physicians still reference. According to these criteria, a diagnosis of alternating hemiplegia of childhood should be considered when several specific features are present. These include the onset of symptoms before 18 months of age, repeated episodes where one side of the body becomes paralyzed (with the paralysis sometimes switching sides or affecting both sides), other unusual movements or symptoms that come and go, complete relief of all symptoms during sleep, and evidence of developmental delays.^[7]

However, diagnostic criteria have evolved over time. More recent proposals suggest dividing symptoms into essential, major, and minor categories, which helps physicians recognize the full spectrum of how the condition can present. This updated approach also acknowledges that finding a specific genetic mutation can support the diagnosis even when not all classic symptoms are present.^[7]

Genetic testing has become a crucial part of the diagnostic process. Around 75 to 80 percent of people with alternating hemiplegia of childhood have a mutation in a specific gene called ATP1A3. This gene provides instructions for making a protein that helps nerve cells in the brain function properly by moving charged particles called sodium and potassium across cell walls. When this protein doesn’t work correctly, it can lead to the episodes of paralysis and other symptoms characteristic of the disorder.^[3]^[6]

Genetic testing can confirm the presence of the ATP1A3 gene mutation, which strongly supports the diagnosis of alternating hemiplegia of childhood. Very rarely, mutations in another gene called ATP1A2 may be involved. The test is typically performed using a blood sample, and results can help distinguish alternating hemiplegia of childhood from other neurological conditions that might cause similar symptoms. Advanced genetic analysis and counseling services are available to help families understand test results and their implications.^[3]

An electroencephalogram, commonly called an EEG, is often performed to help distinguish between alternating hemiplegia of childhood and epilepsy. This test measures the electrical activity in the brain using small sensors attached to the scalp. During an EEG, physicians look for the characteristic wave patterns that appear during epileptic seizures. If the test shows normal brain wave patterns during episodes that look like seizures, this finding supports a diagnosis of alternating hemiplegia of childhood rather than epilepsy. Video EEG monitoring, where the child’s behavior is recorded on video while brain activity is measured, can be particularly valuable for distinguishing epileptic episodes from other types of attacks.^[3]^[7]

Brain imaging studies, particularly magnetic resonance imaging (MRI) scans, are typically performed to rule out structural abnormalities or other medical conditions that could cause episodes of weakness or paralysis. In most cases of alternating hemiplegia of childhood, MRI scans appear normal, which actually helps support the diagnosis by eliminating other possible causes. These imaging tests use powerful magnets and radio waves to create detailed pictures of the brain’s soft tissues without using radiation.^[3]^[7]

Heart monitoring tests play an important role in the diagnostic workup because people with alternating hemiplegia of childhood have a higher risk of developing heart problems. An echocardiogram uses sound waves to create images of the heart’s structure, looking for any abnormalities in how the heart is built. An electrocardiogram, or EKG, measures the heart’s electrical activity to detect any irregular rhythms. These tests help establish baseline heart function and identify any issues that might require special precautions, particularly if the child ever needs sedation or anesthesia for procedures.^[3]^[2]

Sleep studies may be recommended to identify any sleep abnormalities that could affect the child’s health or development. These studies can detect conditions such as obstructive sleep apnea, where breathing temporarily stops during sleep, central sleep apnea, where the brain doesn’t send proper signals to control breathing, or restless legs syndrome. Since sleep provides complete relief from symptoms in alternating hemiplegia of childhood, ensuring that children get good quality sleep becomes especially important.^[3]

Distinguishing alternating hemiplegia of childhood from other conditions requires careful consideration. The differential diagnosis—meaning the list of other conditions that might cause similar symptoms—includes hemiplegic migraine, various forms of epilepsy and epileptic encephalopathy, Moyamoya disease (a rare blood vessel disorder affecting the brain), and other metabolic or genetic disorders. Physicians must carefully evaluate each possibility to arrive at the correct diagnosis.^[7]

⚠️ Important

Genetic testing should be offered early when alternating hemiplegia of childhood is suspected based on clinical symptoms. While genetic testing is not available for every rare disease, finding an ATP1A3 mutation can confirm the diagnosis and spare families from additional invasive testing or ineffective treatments. However, not finding a mutation doesn’t completely rule out the condition, as some cases have other genetic causes or the cause remains unknown.

Diagnostics for Clinical Trial Qualification

When children with alternating hemiplegia of childhood are being considered for enrollment in research studies or clinical trials, they typically undergo a standardized set of diagnostic tests to confirm their eligibility. These qualification criteria help ensure that study participants truly have the condition being investigated and that researchers can accurately measure whether experimental treatments are working.

The foundation of clinical trial qualification usually begins with confirming that the patient meets established diagnostic criteria for alternating hemiplegia of childhood. This includes documenting the presence of alternating episodes of paralysis, the age at which symptoms first appeared (typically before 18 months), the characteristic relief of symptoms with sleep, and evidence of developmental delays. Detailed medical records showing the pattern and frequency of episodes over time help establish that the individual has the specific form of the condition being studied.^[7]

Genetic testing results often form a key eligibility requirement for clinical trials. Many research studies specifically enroll only those patients who have confirmed mutations in the ATP1A3 gene, as this genetic homogeneity helps researchers better understand whether treatments targeting this specific molecular problem are effective. Some trials may focus on particular mutations within the ATP1A3 gene, such as the three most common variants (known as p.Asp801Asn, p.Glu815Lys, and p.Gly947Arg), which are associated with different degrees of symptom severity.^[6]

Baseline neurological assessments are typically required before trial enrollment to document the patient’s current level of functioning. These assessments measure various aspects of development including cognitive abilities, motor skills, adaptive functioning, and learning capabilities. Having this baseline information allows researchers to determine whether an experimental treatment leads to improvements, stabilization, or changes in the child’s abilities over the course of the study.^[8]

Heart function testing is often mandatory for clinical trial participation because of the increased cardiac risks associated with alternating hemiplegia of childhood. Researchers need baseline echocardiograms and electrocardiograms to ensure it’s safe for participants to receive experimental treatments and to monitor whether any investigational drugs affect heart function. Some trials may exclude patients with pre-existing significant heart abnormalities to minimize safety risks.^[2]

Documentation of episode frequency and severity in the weeks or months before trial enrollment helps establish baseline measurements that can be compared to the patient’s condition during and after treatment. Families may be asked to keep detailed diaries recording when episodes occur, how long they last, which parts of the body are affected, and any potential triggers. This information provides objective data about whether experimental treatments reduce the number or intensity of paralytic episodes.

Some clinical trials may require additional specialized testing depending on the nature of the investigational treatment. For example, trials testing drugs that could affect liver function might require baseline liver enzyme tests. Studies investigating treatments that work through specific biological pathways might need blood tests to measure certain proteins or other substances that indicate how the treatment is affecting the body at a molecular level.

Age criteria often factor into clinical trial eligibility, as some studies focus specifically on young children while others enroll adolescents or adults with the condition. The eligibility requirements depend on what the researchers are trying to learn and at what stage of the disease the experimental treatment is thought to be most helpful.

Prognosis and Survival Rate

Prognosis

Alternating hemiplegia of childhood is generally not considered a progressive condition, meaning it does not inevitably worsen over time. However, it does cause long-term problems that persist throughout life. The number and length of paralytic episodes initially tend to worsen throughout childhood but then often begin to decrease over time. Some of the uncontrollable muscle movements may disappear entirely as children grow older, though episodes of paralysis continue to occur throughout adult life.^[1]

The cognitive impact of the condition typically involves some level of developmental delay and intellectual disability affecting almost all individuals. Unfortunately, cognitive functioning often declines over time, though the rate and extent of this decline varies considerably between individuals. Almost all affected people experience some degree of developmental delays affecting learning, movement, and behavioral development, with these problems often being severe.^[1]^[2]

The quality of life for the vast majority of those with alternating hemiplegia of childhood is generally not good. Most affected individuals do not live independently as adults and depend on relatives or group home care. However, there is a growing number of people who are gaining more skills and participating in more typical adult activities such as holding jobs, pursuing artistic endeavors, or forming relationships, thanks in part to advances in treatment options, technology, and mobility aids.^[15]

Factors affecting prognosis include the specific genetic mutation involved. The three most common ATP1A3 mutations are associated with different degrees of severity, with p.Glu815Lys typically causing more severe symptoms than p.Asp801Asn, and p.Gly947Arg generally associated with milder presentations. Early diagnosis and appropriate management can help maximize developmental potential and quality of life, though they cannot cure the underlying condition.^[6]

Survival rate

Alternating hemiplegia of childhood is not generally considered a life-shortening condition in itself. However, some individuals have lost their lives prematurely due to complications related to the disease. These complications can include loss of ability to breathe during severe episodes, seizures in those who develop epilepsy, heart-related issues, or injuries resulting from sudden loss of motor control during attacks. Even one person dying because of issues related to alternating hemiplegia of childhood represents a tragic loss that highlights the seriousness of this condition.^[15]

People with alternating hemiplegia of childhood have a higher risk of developing heart problems later in life, and special precautions must be taken if patients undergo sedation or anesthesia, as they face increased risks of respiratory or cardiac complications during these procedures. These cardiac risks contribute to the overall health challenges faced by individuals with the condition throughout their lives.^[2]

While specific survival statistics are not widely available due to the extreme rarity of the condition, the recognition that alternating hemiplegia of childhood requires lifelong care and can lead to serious complications underscores the importance of comprehensive medical management. Problems may increase with time, making ongoing specialized care essential for optimizing outcomes and preventing life-threatening complications.^[2]

#1 Clinical Trials Search in Europe